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ABSTRACT 
 
 
Insulin resistance (IR) in adolescence is associated with T2DM. The PREVIEW study assesses the effectiveness of a 
high-protein, low-glycaemic index diet and moderate-protein, moderate-glycaemic index diet to decrease IR in 
insulin resistant children with overweight/obesity. Inclusion criteria were age 10-17y, HOMA-IR≥2.0 and 
overweight/obesity. In 126 children (13.6±2.2y, BMI z-score 3.04±0.66, HOMA-IR 3.48±2.28) anthropometrics, 
fat mass percentage (FM%), metabolic parameters, physical activity, food intake and sleep were measured. 
Baseline characteristics did not differ between the groups. IR was higher in pubertal children with morbid obesity 
than in prepubertal children with morbid obesity (5.41±1.86 vs. 3.23±1.86, p=0.007) and prepubertal and 
pubertal children with overweight/obesity (vs. 3.61±1.60, p=0.004 and vs. 3.40±1.50, p<0.001 respectively). IR 
was associated with sex, Tanner stage, BMI z-score, and FM%. Fasting glucose concentrations were negatively 
associated with Baecke Sport (r=-0.223, p=0.025) and positively with daytime sleepiness (r=0.280, p=0.016) 
independent of sex, Tanner stage, BMI z-score and FM%. In conclusion, IR was most severe in pubertal children with 
morbid obesity. The relations between fasting glucose concentration with Baecke Sport and sleepiness suggest these 
might be possible targets for diabetes prevention.  
 
 
 
180 words 
 
INTRODUCTION 
 
Up to  44.0% of children with overweight present with insulin resistance (IR), a precursor of T2DMi. IR is defined as 
the inability of insulin to increase glucose uptake and utilization, leading to a compensatory increase in insulin 
secretion to maintain normal blood glucose values. IR is associated with metabolic disturbances, non-alcoholic fatty 
liver disease (NAFLD) and development of cardiovascular disorders. IR in children is further complicated by a 
physiological transient insulin resistance during puberty, which seems to be more severe in children with overweight 
and obesity1-3. Some children appear to have insufficient β-cell insulin secretion to compensate for the increased IR, 
which puts them at risk for β-cell exhaustion and, ultimately, T2DM3. Thus, puberty may be a critical time for diabetes 
prevention in insulin resistant children with overweight and obesity.  
Previous studies have shown that weight loss improves IR in children with overweight and obesity4. Diets higher in 
protein, especially when combined with lower glycaemic index (GI), have shown to be protective for obesity in 
children5. However, it is not known which dietary strategy is most effective for IR reduction, independent of weight 
change, in high-risk insulin resistant children. The PREVention of diabetes through Lifestyle Intervention and 
population studies in Europe and around the World (PREVIEW) study aims to assess the effectiveness of two dietary 
strategies on reducing IR, independent of weight change, in insulin resistant children at high risk for T2DM. 
Participants were randomized into a moderate-protein, moderate-GI diet, following clinical standards for diabetes 
prevention, or a high-protein, low-GI diet in line with the most successful diet for children in the DiOGenes study5. 
In this paper the study design, methods and baseline results are presented. 
 
 
MATERIALS AND METHODS  
Here we present a concise version of the methods. More information on the study protocol is presented  in the 
Supplement.  
 
1. Participants  
The PREVIEW children study is a randomized trial conducted at three study sites (Maastricht University, the 
Netherlands; University of Navarra, Spain; and Swansea University, United Kingdom). Inclusion criteria included 
age 10-17 years, overweight or (morbid) obesity, IR (HOMA-IR≥2.0 for children Tanner stages ≥3 or any HOMA-
IR for children Tanner stages 1-2), and written informed consent by both parents and children aged ≥12 years. 
Children were excluded from participation in the presence of medical conditions or medication use that might 
compromise study outcomes (e.g. T2DM, bariatric surgery or metformin use) and issues leading to difficulty in 
compliance with the protocol (e.g. severe food intolerances).  
 
2. Design and intervention 
The first 8 weeks of the study were aimed at weight stabilization in spite of growth. Children received a 
personalized menu following the recommended guidelines of 15/55/30 energy percentage (En%) 
protein/carbohydrate/fat. In the 96-weeks intervention phase children were randomized into a moderate-protein 
moderate-GI arm (MPMGI) consisting of a target macronutrient composition of 15/55/30En% 
protein/carbohydrate/fat, and a GI≥56, or a high-protein, low-GI arm (HPLGI) consisting of 25/45/30En% 
protein/carbohydrate/fat and a GI≤50 (Supplementary Table 1). Children received personalized menus and 
recipes in line with their randomization arm and energy needs. All children received instructions on both high-intensity 
and moderate-intensity physical activity (PA) and exercise in general was encouraged. Nutritional and PA 
counselling was provided at each visit to improve compliance. The study protocol was approved by local Medical 
Ethics Committees and was compliant with the Declaration of Helsinki and the ICH-GCP. The trial was registered on 
ClinicalTrials.gov (number NCT01777893). 
 
3. Measurements 
Measurements were performed during standardized clinical investigation days (CIDs) (Supplementary Table 2).  
3.1 Anthropometric measurements and body composition 
Height and weight were measured while children were in fasted state, barefoot, and wearing only underwear. 
Subsequently body mass index (BMI), age- and sex-specific BMI z-scores and overweight classifications were 
calculated6. Body composition was measured using air-displacement plethysmography or bio-impedance 
measurements. Children were classified as prepubertal (Tanner genital/mammae stages 1-2) or pubertal (Tanner 
stages 3-5)7,8.  
 3.2 Parameters of glucose metabolism, lipids, inflammation, and liver parameters and blood pressure 
After an overnight fast, a blood sample was taken to assess glucose metabolism parameters, lipids, markers of 
inflammation and liver parameters (Table 1 & Supplementary Table 2). Insulin sensitivity was assessed by Homeostatic 
Model Assessment of Insulin Resistance (HOMA-IR; glucose (mmol/L) * insulin (mU/L) / 22,5)9. Children were defined 
as insulin resistant when HOMA-IR≥2.0 or any HOMA-IR for prepubertal children due to a physiologically lower 
HOMA-IR in early puberty2. An average of three blood pressure measurements was used for analyses.  
3.3 Lifestyle factors: food intake behaviour, physical activity and sleep 
Children completed a 4-day food record to assess energy intake, macronutrient composition, glycaemic index and 
glycaemic load (GL). The three Factor Eating Questionnaire (TFEQ) adapted for children was used to assess food 
intake behaviour10. In a subcohort at UM 24h urinary nitrogen was obtained to calculate protein intake. PA was 
measured by 7-day accelerometry using an Actigraph (Actigraph GT3X accelerometer) and by the Baecke 
questionnaire adapted for children11. The Pittsburgh Sleep Quality Index (PSQI) and Epworth Sleepiness Scale (ESS) 
were used to assess self-reported sleep parameters12,13. In a subcohort sleep was measured using 
polysomnography.  
 
4. Statistical analyses 
In future analyses, effects of the two dietary arms will be compared using ANOVA repeated measures with diet as 
a factor. Multiple regression analyses will be used to identify the contribution of different variables to HOMA-IR 
change. Baseline analyses in this paper were performed using the Statistical Package for the Social Sciences (SPSS) 
24.0 (SPSS Inc, New York). ANOVA or Mann-Whitney-U test were used for assessing differences between the two 
intervention groups, depending on normality of data. Associations between parameters were assessed using 
Pearson’s or Spearman’s correlation coefficients, which were corrected for relevant variables. A p-value <0.05 was 
considered statistically significant.  
 
RESULTS 
126 children that completed screening and body composition measurement were included in baseline analyses 
(58.7% girls, age 13.6±2.2y, BMI z-score 3.04±0.66, HOMA-IR 3.35±1.80, 31.0/46.0/23.0% 
overweight/obesity/morbid obesity, Figure 1 and Table 1). Participant characteristics were not significantly 
different between the HPLGI and MPMGI groups.  
HOMA-IR distribution in high-risk children (HOMA-IR≥2.0) did not differ between children in different Tanner stages 
or between the sexes (Supplementary Figure 1). IR was higher in pubertal children with morbid obesity than in 
prepubertal children with morbid obesity (5.41±1.86 vs. 3.23±1.86, p=0.007), and prepubertal and pubertal 
children with overweight/obesity (vs. 3.61±1.60, p=0.004 and 3.40±1.50, p<0.001 respectively).  
Parameters of glucose metabolism were positively associated with sex, Tanner stage, BMI z-score, fat mass index, 
fat free mass index and FM%. Independently of sex, Tanner stage, BMI z-score and FM%, Baecke Sport score was 
inversely (r= -0.223, p=0.025) and ESS daytime sleepiness positively (r=0.280, p=0.016) associated with fasting 
blood glucose concentrations (Supplementary Table 3).  
Drop-out analyses showed no differences between children that completed the PA and food intake questionnaires 
and children that did not. Children that completed sleep questionnaires had a higher FFMI (19.0±2.6 vs. 
17.3±2.4kg/m2, p=0.001), lower FM% (37.1±9.3 vs. 40.4±7.1%, p=0.027) and higher fasting blood glucose 
concentration (4.8±0.7 vs. 4.4±0.7mmol/L, p=0.007) than children that did not complete these questionnaires 
(Supplementary Table 4).  
 
 
DISCUSSION 
 
This paper describes the methods and baseline analyses of the PREVIEW children study. PREVIEW is the first 
international randomized trial to assess the effects of a high-protein, low-GI and moderate-protein, moderate-GI 
diet on IR in insulin resistant children, independent of weight changes and puberty. In addition, the longitudinal 
follow-up (2y) in the PREVIEW study will help fill a gap in the knowledge of HOMA-IR development during puberty 
in at risk children.  
It has been shown that a reduction in BMI is associated with IR reduction in children with overweight and obesity4. 
The DiOGenes study showed that a diet with a higher protein content, especially when combined with a lower GI, 
significantly decreased the percentage of overweight and obesity in children of all ages5. This study also found 
that the HP-LGI diet improved glucose metabolism even in the absence of BMI z-score changes14. Other studies 
focussing on IR in children often included metformin prescription, which hinders evaluation of the independent effects 
of diet and physical activity on IR15. Unique about the PREVIEW study is that it studies the impact of a dietary 
intervention on IR, independent of weight changes, in an at-risk group of insulin resistant children with 
overweight/obesity during puberty, without providing metformin.  
Baseline subject characteristics were not significantly different between the two intervention groups, demonstrating 
good randomization. No differences were found in HOMA-IR between children in different Tanners stages or 
between the sexes, which is probably due to including only high-risk children (HOMA-IR≥2.0) in these analyses.  
As expected, pubertal children with morbid obesity had a significantly higher HOMA-IR than prepubertal children 
or children with overweight. High HOMA-IR in children with morbid obesity in this and previous studies indicates that 
these children especially are at high risk for β-cell exhaustion, which can result in decreased and insufficient β-cell 
secretion and T2DM2,3,16. The PREVIEW study aims to provide more insight in longitudinal insulin resistance 
development during puberty in a 2y follow-up design.   
We confirmed that in insulin resistant children with overweight and obesity, parameters of glucose metabolism are 
associated with increasing puberty stages and markers of adiposity (BMI z-score, FFMI, FMI and FM%)1. Physical 
activity, measured as Baecke Sport score, appeared to be inversely associated with fasting blood glucose 
concentrations, independent of sex, Tanner stage, BMI z-score and FM%. However, glucose concentrations and 
accelerometry counts were not related, and Baecke scores were not associated with accelerometry counts. Fasting 
blood glucose concentrations were positively related to ESS daytime sleepiness. 
Strengths of the PREVIEW study are the assessment and monitoring of a wide range of targets associated with 
reduction of IR, i.e. diet, PA and sleep in pubertal children at risk, and the international setting. Limitations are the 
absence of a normal weight control group due to ethical considerations of research in children. Since the research 
was set in free-living conditions, compliance with the protocol may vary. Response to some lifestyle assessments 
using questionnaires was quite low due to refusal to answer questionnaires or incomplete questionnaires, limiting 
interpretation of lifestyle-related outcomes of the intervention. Drop-out analyses revealed some differences 
between children that did and did not complete all assessments, which will be taken into account in future analyses 
(Supplementary Table 4).  
In conclusion, the PREVIEW study is a randomized trial aiming to assess the most effective diet for preventing IR 
increase, independent of weight change, and corrected for puberty stage, in at risk children with overweight and 
obesity. Baseline characteristics did not differ between the HPLGI and the MPMGI intervention arms.  In children 
with overweight and obesity at risk for T2DM development, IR was most severe in pubertal children with morbid 
obesity. IR was associated with sex, adiposity and Tanner stage. Fasting glucose concentrations were independently 
inversely related to Baecke sport and positively to sleepiness, indicating these might be possible tools for diabetes 
prevention.   
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Figure 1. Flowchart of participants in the PREVIEW children study 
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Table 1. Anthropometric characteristics, parameters of glucose metabolism, lipids, 
inflammation, liver parameters and cardiovascular risk at baseline  
 
All participants 
(n=126)  HPLGI (n=68)  MPMGI (n=58)  p-value 
  mean ± SD   mean ± SD   mean ± SD     
Female (n; %) 74 (58.7%)  39 (57.4%)  35 (60.3%)  0.856 
Age (yr) 13.6 ± 2.2  13.7  2.4  13.4  2.0  0.512 
Tanner G/M stage (median (IQR)) 3 (2 - 4)  3 (2 - 5)  3 (2 - 4)  0.440 
Anthropometric characteristics                           
Height (m) 1.61 ± 0.11  1.61 ± 0.11  1.60 ± 0.10  0.695 
Weight (kg) 78.0 ± 19.7  80.0 ± 20.9  75.7 ± 18.2  0.472 
BMI (kg/m2) 29.8 ± 4.9  30.1 ± 5.1  29.3 ± 4.6  0.536 
BMI z-score 3.04 ± 0.66  3.10 ± 0.69  2.97 ± 0.63  0.543 
IOTF class (median (IQR)) 2 (1 - 2)   2 (1 - 3)  2 (1 - 2)  0.205 
Body composition                           
Fat free mass index (kg/m2) 17.9 ± 2.6  18.0 ± 2.8  17.9 ± 2.4  0.985 
Fat mass index (kg/m2) 11.8 ± 3.9  12.3 ± 3.9  11.4 ± 3.9  0.297 
Fat mass (%) 39.2 ± 8.1  40.0 ± 7.4  38.2 ± 8.9  0.379 
Parameters of glucose metabolism                           
Glucose (mmol/L) 4.6 ± 0.7  4.6 ± 0.68  4.5 ± 0.7  0.132 
Insulin (pmol/L) 109.6 ± 74.2  107.2 ± 51.5  112.4 ± 94.6  0.482 
HOMA-IR 3.35 ± 1.80  3.44 ± 1.66  3.24 ± 1.96  0.294 
HbA1c (mmol/l) 32.7 ± 2.7  32.7 ± 2.9  32.8 ± 2.5  0.800 
C-peptide (nmol/L) 0.9 ± 0.3  0.9 ± 0.3  0.9 ± 0.3  0.844 
Lipids                           
Total cholesterol (mmol/L) 4.1 ± 0.8  4.1 ± 0.7  4.2 ± 0.8  0.894 
HDL (mmol/L) 1.3 ± 0.3  1.3 ± 0.3  1.3 ± 0.3  0.763 
LDL (mmol/L) 2.4 ± 0.6  2.4 ± 0.6  2.4 ± 0.7  0.650 
TAG (mmol/L) 1.1 ± 0.5  1.1 ± 0.5  1.1 ± 0.6  0.562 
FFA (mmol/L) 0.7 ± 0.2  0.7 ± 0.3  0.6 ± 0.2  0.321 
Inflammation                           
CRP (mg/L) 2.9 ± 3.1  2.9 ± 2.7  3.0 ± 3.5  0.393 
Liver parameters                           
ASAT (U/L) 25.1 ± 8.1  23.9 ± 7.4  26.6 ± 8.8  0.063 
ALAT (U/L) 24.7 ± 14.6  23.5 ± 13.8  26.2 ± 15.5  0.182 
Cardiovascular parameters                           
Systolic blood pressure (mmHg) 116 ± 12  117 ± 13  116 ± 12  0.949 
Diastolic blood pressure (mmHg) 67 ± 8  67 ± 8  66 ± 7  0.316 
Heart rate (beats per minute) 75 ± 12  76 ± 13  74 ± 10  0.432 
Physical activity (n=107)                           
Baecke Work 2.5 ± 0.4  2,4 ± 0,3  2,6 ± 0,4  0.053 
Baecke Sport 2.8 ± 0.5  2,7 ± 0,5  2,8 ± 0,5  0.657 
Baecke Leisure 2.8 ± 0.7  2,9 ± 0,6  2,8 ± 0,7  0.740 
Baecke total  8.1 ± 1.0  8,0 ± 1,0  8,2 ± 1,1  0.451 
Counts (counts per minute)a 306.7 ± 108.5  316,6 ± 101,9  291,0 ± 118,7  0.352 
Food intake behaviour (n=73)                           
TFEQ cognitive restraint of eating  11,0 ± 3,8  10,6 ± 3,6  11,5 ± 4,1  0.307 
TFEQ disinhibition 6,2 ± 3,3  6,7 ± 3,5  5,4 ± 3,0  0.092 
TFEQ hunger 5,4 ± 3,3  5,8 ± 3,7  4,9 ± 2,5  0.414 
GI b 52.4 ± 8.2  50.9 ± 7.7  54.3 ± 8.7  0.140 
GL b 97.9 ± 35.4  93.4 ± 30.9  103.0 ± 32.8  0.193 
Energy intake (kJ/day) b 6958 ± 1957  6674 ± 1613  7341 ± 2326  0.219 
Fat (En%) b 25.7 ± 7.4  35.9 ± 7.8  35.4 ± 6.9  0.909 
Carbohydrates (En%) b 45.1 ± 7.1  44.7 ± 7.8  45.6 ± 6.1  0.643 
Protein (En%) b 17.2 ± 3.0  17.5 ± 2.4  16.9 ± 3.7  0.496 
Fibre (g) b 14.0 ± 5.5  13.9 ± 5.0  14.1 ± 6.2  0.897 
Estimated protein intake (g/kg/d)c 0.48 ± 0.38  0.52 ± 0.49  0.44 ± 0.21  0.458 
Sleep assessment (n=68)                           
TST (min) 466 ± 70  463 ± 61  469 ± 79  0.521 
REM (min) 107 ± 59  110 ± 78  102 ± 30  0.309 
SWS (min) 135 ± 65  141 ± 83  128 ± 39  0.803 
WASO (min) 45 ± 70  50 ± 92  40 ± 37  0.637 
QS (%) 50.5 ± 10.1  51 ± 10  50 ± 10  0.934 
Sleep questionnaires (n=48)                           
ESS 5.7 ± 4.0  6.3 ± 4.3  4.9 ± 3.4  0.249 
PSQI Total score 3.7 ± 2.1  3.9 ± 2.2  3.4 ± 2.0  0.438 
PSQI Sleep quality  0.7 ± 0.6  0.9 ± 0.6  0.5 ± 0.6  0.061 
PSQI Sleep latency  0.7 ± 1.0  0.8 ± 1.0  0.6 ± 0.8  0.575 
PSQI Sleep duration 0.4 ± 0.7  0.5 ± 0.7  0.3 ± 0.6  0.556 
PSQI Sleep efficiency 0.2 ± 0.6  0.5 ± 0.7  0.3 ± 0.6  0.765 
PSQI Sleep disturbances 1.0 ± 0.6  1.0 ± 0.6  1.1 ± 0.7  0.437 
PSQI Sleeping medications  0.1 ± 0.5  0.1 ± 0.6  0.2 ± 0.5  0.732 
PSQI Daytime dysfunction  0.4 ± 0.6   0.4 ± 0.6   0.4 ± 0.6   0.804 
Data presented as mean ± SD or median (interquartile range). Tanner G/M stage = Tanner stage for genitals 
(boys8) or mammae (girls7); BMI = Body Mass Index; IOTF = International Obesity Task Force overweight class6; 
HOMA-IR = Homeostatic Model Assessment of Insulin Resistance9; HDL-cholesterol = high density lipoprotein-
cholesterol; LDL-cholesterol = low density lipoprotein-cholesterol; TAG = triacylglycerides; CRP = c-reactive 
protein; AST = aspartate transaminase; ALT = alanine transaminase ; TFEQ = Three Factor Eating 
Questionnaire10; PSQI = Pittsburgh Sleep Quality Index12; ESS = Epworth Sleep Scale questionnaire13; TST = 
total sleep time; REM = Rapid Eye Movement Sleep; SWS = Slow Wave Sleep; WASO = Wake after Sleep 
Onset; QS = Quality of Sleep ( (REM + SWS) / TST). a n=67. b n=54. c n=27. 
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